These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 27010145
1. Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. Ormeci A, Emrence Z, Baran B, Gokturk S, Soyer OM, Evirgen S, Akyuz F, Karaca C, Besisik F, Kaymakoglu S, Ustek D, Demir K. Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):879-85. PubMed ID: 27010145 [Abstract] [Full Text] [Related]
2. Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis. Zhao F, Wang J, Yang Y, Wang X, Shi R, Xu Z, Huang Z, Zhang G. Helicobacter; 2008 Dec; 13(6):532-41. PubMed ID: 19166419 [Abstract] [Full Text] [Related]
6. Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan. Dojo M, Azuma T, Saito T, Ohtani M, Muramatsu A, Kuriyama M. Dig Liver Dis; 2001 Nov 16; 33(8):671-5. PubMed ID: 11785712 [Abstract] [Full Text] [Related]
8. Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosage. Kang JM, Kim N, Lee DH, Park YS, Kim JS, Chang IJ, Song IS, Jung HC. J Gastroenterol Hepatol; 2008 Aug 16; 23(8 Pt 1):1287-91. PubMed ID: 18637061 [Abstract] [Full Text] [Related]
11. Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism. Hokari K, Sugiyama T, Kato M, Saito M, Miyagishima T, Kudo M, Nishikawa K, Ishizuka J, Komatsu Y, Mizushima T, Kagaya H, Hige S, Takeda H, Asaka M. Aliment Pharmacol Ther; 2001 Sep 16; 15(9):1479-84. PubMed ID: 11552922 [Abstract] [Full Text] [Related]
12. Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin. Oh JH, Dong MS, Choi MG, Yoo HW, Lee SB, Park YI, Chung IS. J Gastroenterol Hepatol; 2009 Feb 16; 24(2):294-8. PubMed ID: 18823430 [Abstract] [Full Text] [Related]
14. [Effect of CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with rabeprazole-based triple therapy in Chinese]. He XX, Zhao YH, Hao YT. Zhonghua Nei Ke Za Zhi; 2004 Jan 16; 43(1):13-5. PubMed ID: 14990013 [Abstract] [Full Text] [Related]
19. The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. Padol S, Yuan Y, Thabane M, Padol IT, Hunt RH. Am J Gastroenterol; 2006 Jul 16; 101(7):1467-75. PubMed ID: 16863547 [Abstract] [Full Text] [Related]